1. Cooney DA, Jayaram H, Gebeyehu G, Betto C, Kelley J, Marquez V, Johns D: The Conversion of 2-B-D-ribofuranosylthiazole-4-carboxamide to an Analogue of NAD with Potent IMP dehydrogenase-Inhibitory Properties. Biochem Pharmacol 31: 2133–2136
2. Stewart DJ, Leavens M, Friedman J, Benjamin RS, Moore EC, Bodey GP, Valdivieso M, Burgess MA, Wiseman C, Loo TL: Penetration of N-(Phosphonacetul)-L-aspartate into Human Central Nervous System and Intracerebral Tumor. Cancer Research 40: 3163–3166, 1980
3. Stewart DJ, Benvenuto JA, Leavens M, Hall SW, Benjamin RS, Plunkett W, McCredie KD, Burgess MA, Loo TL: Penetration of 3-Deazauridine into Human Brain. Intracerebral Tumor, and Cerebrospinal Fluid. Cancer Research 39: 4119–4122, 1979
4. Ho DHW, Frei E: Clinical Pharmacology of 1-B-D-Arabinofuranosylcytosine. Clin Pharmacol Ther 12: 944–954, 1971
5. Stewart DJ, Leavens M, Maor M, Feun L, Luna M, Bonura J, Caprioli R, Loo TL, Benjamin RS: Human Central Nervous System Distribution of Cis-Diamminedichloroplatinum and Use as a Radiosensitizer in Malignant Brain Tumors. Cancer Research 42: 2474–2479, 1982